Private Investment In A Public Entity (Pipe) Financings
Jan. 1, 1998
Number of Shares
Share Unit Price
Alexion Pharmaceuticals Inc.
Alexion sold 1.45M shares of common stock to institutional investors at $7.72/share, a 9 0iscount from the 10-day trading average of its traded stock price; the company will register the shares for resale; BancAmerica Robertson Stephens & Co. LLC acted as the placement agent (6/97)
Inhale Therapeutic Systems
A number of institutional investors bought 1.8M newly issued shares of Inhale stock at $18.00/share; the company registered the shares for re-sale; Vector Securities International Inc. acted as the placement agent (1/97)
Interferon Sciences Inc.
The company sold 1.93M unregistered shares of common stock primarily to institutional investors; Sunrise Securities Corp. acted as the placement agent (8/97)
Matritech sold 2.2M shares at $5.00 each (a 3 0iscount to market); Sunrise Securities Corp. acted as the placement agent (5/97)